Immunotherapy with Keytruda (Pembolizumab) Doctors Abroad — Page 2

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.

Associate Professor Tahsin Ozatli is a specialist medical oncologist at Istinye University Liv Hospital with a focus on targeted therapies for complex cancers.

• Specialises in treatment plans for breast, lung, and gastrointestinal malignancies
• Achieved the rank of Associate Professor in 2016 for his contributions to oncology
• Gained extensive expertise at the dedicated Ankara Oncology Clinic
• Trained at the Regional Training and Research Hospital in Erzurum
• Expert in managing systemic treatments across diverse internal medicine cases

Professor Mustafa Serkan Alemdar is a medical oncology specialist at Medical Park Antalya with deep roots in academic medicine at Akdeniz University.

• Triple-specialised in medicine, internal medicine, and medical oncology
• Served as a senior specialist at Akdeniz University Hospital for over a decade
• Expertise includes modern immunotherapy protocols for complex solid tumours
• Active researcher in the field of clinical oncology and patient outcomes

Professor Ercan Ozden is a dual-qualified specialist in internal medicine and medical oncology at VM Medical Park Pendik Hospital.

• Completed the English Medical Programme at Istanbul University Cerrahpasa Faculty of Medicine
• Expert in medical oncology subspecialty focusing on targeted systemic therapies
• Manages complex treatment plans involving immunotherapy for various solid tumours
• Trained at Kocaeli University Faculty of Medicine in advanced oncological care

Associate Professor Muhammed Mustafa Atci is a leading medical oncologist at İstinye University Liv Hospital with a strong focus on advanced immunotherapy protocols.

• Coordinates medical oncology education for the Ministry of Health – teaching the next generation of specialists
• Expert in treating residual triple-negative breast cancer with targeted chemotherapy and immunotherapy combinations
• Active researcher in BRCA mutation profiles and hereditary cancer risks
• Member of the American Society of Clinical Oncology (ASCO) since 2018
• Published extensive research on survival impacts of emerging treatments in international peer-reviewed journals

Professor Irfan Cicin is a senior medical oncologist and academic lead at Trakya University Faculty of Medicine, where he oversees complex cancer treatment protocols.

• Specialised in medical oncology at Trakya University, focusing on modern drug therapies
• Holds the title of Professor of Medical Oncology, the highest academic rank in Turkey
• Served as a physician for the Turkish Air Force Command at Etimesgut Military Hospital
• Practises at İstinye University Liv Hospital Topkapı, a major centre for oncology research
• Expertise includes managing targeted immunotherapy regimes for various solid tumour types